Cargando…

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa

BACKGROUND: In 2015 South Africa established a national cryptococcal antigenemia (CrAg) screening policy targeted at HIV-infected patients with CD4+ T-lymphocyte (CD4) counts <100 cells/ μl who are not yet on antiretroviral treatment (ART). Two screening strategies are included in national guidel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larson, Bruce A., Rockers, Peter C., Bonawitz, Rachael, Sriruttan, Charlotte, Glencross, Deborah K., Cassim, Naseem, Coetzee, Lindi M., Greene, Gregory S., Chiller, Tom M., Vallabhaneni, Snigdha, Long, Lawrence, van Rensburg, Craig, Govender, Nelesh P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938608/ https://www.ncbi.nlm.nih.gov/pubmed/27390864 http://dx.doi.org/10.1371/journal.pone.0158986

Ejemplares similares

Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease
por: Coetzee, Lindi-Marie, et al.
Publicado: (2018)

District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa
por: Cassim, Naseem, et al.
Publicado: (2018)

Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals
por: Cassim, Naseem, et al.
Publicado: (2017)

Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa
por: Cassim, Naseem, et al.
Publicado: (2017)

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach
por: Cassim, Naseem, et al.
Publicado: (2018)

Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi
por: Chisale, Master R. O., et al.
Publicado: (2023)

An Integrated Tiered Service Delivery Model (ITSDM) Based on Local CD4 Testing Demands Can Improve Turn-Around Times and Save Costs whilst Ensuring Accessible and Scalable CD4 Services across a National Programme
por: Glencross, Deborah K., et al.
Publicado: (2014)

Using laboratory data to categorise CD4 laboratory turn-around-time performance across a national programme
por: Coetzee, Lindi-Marie, et al.
Publicado: (2018)

Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa
por: Cassim, Naseem, et al.
Publicado: (2020)

Weekly laboratory turn-around time identifies poor performance masked by aggregated reporting
por: Coetzee, Lindi-Marie, et al.
Publicado: (2020)

Newly implemented community CD4 service in Tshwaragano, Northern Cape province, South Africa, positively impacts result turn-around time
por: Coetzee, Lindi-Marie, et al.
Publicado: (2022)

Modelling CD4 reagent usage across a national hierarchal network of laboratories in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

Estimating Implementation and Operational Costs of an Integrated Tiered CD4 Service including Laboratory and Point of Care Testing in a Remote Health District in South Africa
por: Cassim, Naseem, et al.
Publicado: (2014)

Compliance to HIV treatment monitoring guidelines can reduce laboratory costs
por: Cassim, Naseem, et al.
Publicado: (2016)

Programmatic implications of implementing the relational algebraic capacitated location (RACL) algorithm outcomes on the allocation of laboratory sites, test volumes, platform distribution and space requirements
por: Cassim, Naseem, et al.
Publicado: (2017)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

Timely delivery of laboratory efficiency information, Part I: Developing an interactive turnaround time dashboard at a high-volume laboratory
por: Cassim, Naseem, et al.
Publicado: (2020)

Assessing CD4 rejections across a national laboratory service for 2018 in South Africa: highlighting the importance of adherence to national handbook guidelines
por: Cassim, Naseem, et al.
Publicado: (2022)

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic
por: Reepalu, Anton, et al.
Publicado: (2015)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
por: Cassim, Naseem, et al.
Publicado: (2021)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
por: Huang, Sung-Hsi, et al.
Publicado: (2021)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease
por: Wake, Rachel M, et al.
Publicado: (2022)

High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
por: Alemu, Abere Shiferaw, et al.
Publicado: (2013)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

Timely delivery of laboratory efficiency information, Part II: Assessing the impact of a turn-around time dashboard at a high-volume laboratory
por: Cassim, Naseem, et al.
Publicado: (2020)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2023)

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2020)

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
por: Quan, Vanessa, et al.
Publicado: (2019)

No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia
por: Smitson, Christopher C., et al.
Publicado: (2014)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2021)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
por: Ganiem, Ahmad Rizal, et al.
Publicado: (2014)

Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau
por: Thomsen, Ditte, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m605e1e84d32i1gp4k4r0c6teh